Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway

Title
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
Authors
Keywords
Empagliflozin, Cardiac microvascular I/R injury, AMPKα1/ULK1 pathway, FUNDC1-Dependent mitophagy
Journal
Redox Biology
Volume 52, Issue -, Pages 102288
Publisher
Elsevier BV
Online
2022-03-18
DOI
10.1016/j.redox.2022.102288

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started